Benjamin Haynor
Stock Analyst at Lake Street
(1.54)
# 3,458
Out of 5,044 analysts
12
Total ratings
36.36%
Success rate
0.39%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INFU InfuSystem Holdings | Assumes: Buy | $15 | $10.37 | +44.72% | 1 | Sep 22, 2025 | |
| ELMD Electromed | Assumes: Buy | $36 | $23.99 | +50.09% | 1 | Aug 27, 2025 | |
| PROF Profound Medical | Maintains: Buy | $17 → $11 | $6.02 | +82.64% | 1 | Apr 23, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $39.00 | -51.28% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $8.50 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $1,400 | $14.00 | +9,900.00% | 1 | Aug 29, 2017 | |
| SRDX Surmodics | Initiates: Buy | $44 | $27.00 | +61.11% | 1 | Jun 27, 2017 |
InfuSystem Holdings
Sep 22, 2025
Assumes: Buy
Price Target: $15
Current: $10.37
Upside: +44.72%
Electromed
Aug 27, 2025
Assumes: Buy
Price Target: $36
Current: $23.99
Upside: +50.09%
Profound Medical
Apr 23, 2025
Maintains: Buy
Price Target: $17 → $11
Current: $6.02
Upside: +82.64%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $39.00
Upside: -51.28%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $8.50
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $1,400
Current: $14.00
Upside: +9,900.00%
Surmodics
Jun 27, 2017
Initiates: Buy
Price Target: $44
Current: $27.00
Upside: +61.11%